SLE patients often exhibit the key features of the immune risk phenotype, an inverted CD4+/CD8+ ratio, due to CD8+ T cell expansion and a higher CD4+ T cell turnover (335). This evidence concerns the gene CD4 and systemic lupus erythematosus.